Ivan Bergstein
2018
In 2018, Ivan Bergstein earned a total compensation of $9.4M as President and Chief Executive Officer at Stemline Therapeutics, a 177% increase compared to previous year.
Compensation breakdown
| Bonus | $673,547 |
|---|---|
| Non-Equity Incentive Plan | $277,637 |
| Salary | $598,708 |
| Stock Awards | $7,891,761 |
| Total | $9,441,653 |
Bergstein received $7.9M in stock awards, accounting for 84% of the total pay in 2018.
Bergstein also received $673.5K in bonus, $277.6K in non-equity incentive plan and $598.7K in salary.
Rankings
In 2018, Ivan Bergstein's compensation ranked 762nd out of 14,244 executives tracked by ExecPay. In other words, Bergstein earned more than 94.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 762 out of 14,244 | 95th |
Division Manufacturing | 251 out of 5,765 | 96th |
Major group Chemicals And Allied Products | 72 out of 2,128 | 97th |
Industry group Drugs | 55 out of 1,817 | 97th |
Industry Pharmaceutical Preparations | 38 out of 1,391 | 97th |
Source: SEC filing on April 30, 2019.
Bergstein's colleagues
We found two more compensation records of executives who worked with Ivan Bergstein at Stemline Therapeutics in 2018.